2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mesalamine provides a new therapeutic approach in treating Crohn's disease.

          Related collections

          Author and article information

          Journal
          Gastroenterology
          Gastroenterology
          Elsevier BV
          00165085
          February 1993
          February 1993
          : 104
          : 2
          : 435-439
          Article
          10.1016/0016-5085(93)90411-5
          8425685
          95818d04-ea0d-4dde-b966-c296b1867296
          © 1993

          http://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article